NCT00717678View on ClinicalTrials.gov

A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Kidney TransplantationTransplantation ImmunologyHost vs Graft Reaction
Interventions
DRUG

Prograf-XL

oral

DRUG

Prograf

oral

DRUG

MMF

oral

Trial Locations (5)

100

Taipei

112

Taipei

333

Taoyuan District

407

Taichung

704

Tainan City

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Taiwan, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY